NCT05969080 Self-Injury Treatment and Recovery in Veterans
| NCT ID | NCT05969080 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Self-Injurious Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-10-15 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-10-15 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times higher than the general population. Moreover, NSSI is associated with increased risk for violence, psychiatric distress, and marked impairment in psychosocial functioning. Even though NSSI is distinct from suicidal behaviors in several important ways, NSSI remains a strong predictor of a future suicide attempt. The primary goal of this project is to evaluate the treatment and acceptability of a brief intervention for NSSI that aims to reduce psychosocial impairment and NSSI behaviors in Veterans.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Past service in the United States military * Nonsuicidal self-injury engagement on 2 occasions in past 30 days * Fluent in English * Able to provide voluntary informed consent Exclusion Criteria: * Lifetime history of psychosis, mania, or hypomania * Imminent risk for suicide/homicide warranting immediate intervention * Unable/unwilling to complete study procedures
Contact & Investigator
Tate F Halverson, PhD
PRINCIPAL INVESTIGATOR
Durham VA Medical Center, Durham, NC
Frequently Asked Questions
Who can join the NCT05969080 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Self-Injurious Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05969080 currently recruiting?
Yes, NCT05969080 is actively recruiting participants. Contact the research team at Tate.Halverson@va.gov for enrollment information.
Where is the NCT05969080 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT05969080 clinical trial?
NCT05969080 is sponsored by VA Office of Research and Development. The principal investigator is Tate F Halverson, PhD at Durham VA Medical Center, Durham, NC. The trial plans to enroll 40 participants.